The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

PDL BioPharma to Hold Annual Meeting of Stockholders on May 21, 2013

Wednesday, March 06, 2013

PDL BioPharma to Hold Annual Meeting of Stockholders on May 21, 201316:05 EST Wednesday, March 06, 2013INCLINE VILLAGE, Nev., March 6, 2013 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the company will hold its annual meeting of stockholders on Tuesday, May 21, 2013, at 10:00 a.m. Pacific Time for all stockholders of record on March 28, 2013. The meeting will take place at the Hyatt Regency Hotel in Incline Village, Nevada.  (Logo: http://photos.prnewswire.com/prnh/20110822/SF55808LOGO) About PDL BioPharma PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Today, PDL is focused on intellectual property asset management, investing in new income generating assets and maximizing value for its shareholders. For more information, please visit www.pdl.com. NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.  SOURCE PDL BioPharma, Inc.For further information: John McLaughlin, PDL BioPharma, Inc., +1-775-832-8500, John.McLaughlin@pdl.com or Jennifer Williams, Cook Williams Communications, +1- 360-668-3701, jennifer@cwcomm.org